Significant projected savings with expansion of an emergency department observation protocol for mild acute pancreatitis

IF 2.8 2区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY

Pancreatology Pub Date : 2025-02-01 DOI:10.1016/j.pan.2024.12.009

Nikhil Thiruvengadam , Kelsey L. Anderson , Sunil G. Sheth

{"title":"Significant projected savings with expansion of an emergency department observation protocol for mild acute pancreatitis","authors":"Nikhil Thiruvengadam , Kelsey L. Anderson , Sunil G. Sheth","doi":"10.1016/j.pan.2024.12.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Acute pancreatitis (AP) significantly contributes to healthcare costs, but not all patients require hospitalization. A novel, validated Emergency Department (ED) pathway for mild AP (MAP) at our tertiary care center reduced hospitalizations and resource utilization, without affecting outcomes.</div></div><div><h3>Methods</h3><div>A decision-analytic model was constructed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist and methodologic recommendations by the Second Panel on Cost-Effectiveness in Health and Medicine to predict healthcare costs based on whether an ED discharge protocol for MAP was utilized.</div></div><div><h3>Results</h3><div>Average savings for one MAP discharged from the ED were $1720.5 compared to the standard of care hospitalization. Assuming that 67.7 % of cases are mild and that there are 288,820 hospitalizations for AP annually, the ED discharge pathway would result in $98.6 million direct healthcare savings.</div></div><div><h3>Conclusions</h3><div>Implementation of an evidence-based, protocoled ED pathway for MAP could result in over $100 million in direct healthcare savings.</div></div>","PeriodicalId":19976,"journal":{"name":"Pancreatology","volume":"25 1","pages":"Pages 35-38"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pancreatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1424390324008378","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Acute pancreatitis (AP) significantly contributes to healthcare costs, but not all patients require hospitalization. A novel, validated Emergency Department (ED) pathway for mild AP (MAP) at our tertiary care center reduced hospitalizations and resource utilization, without affecting outcomes.

Methods

A decision-analytic model was constructed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist and methodologic recommendations by the Second Panel on Cost-Effectiveness in Health and Medicine to predict healthcare costs based on whether an ED discharge protocol for MAP was utilized.

Results

Average savings for one MAP discharged from the ED were $1720.5 compared to the standard of care hospitalization. Assuming that 67.7 % of cases are mild and that there are 288,820 hospitalizations for AP annually, the ED discharge pathway would result in $98.6 million direct healthcare savings.

Conclusions

Implementation of an evidence-based, protocoled ED pathway for MAP could result in over $100 million in direct healthcare savings.

查看原文本刊更多论文

随着轻度急性胰腺炎急诊科观察方案的扩展，预计将显著节省费用。

背景：急性胰腺炎（AP）显著增加了医疗费用，但并非所有患者都需要住院治疗。在我们的三级保健中心，一种新颖的、经过验证的急诊科（ED）治疗轻度AP （MAP）的途径减少了住院率和资源利用率，而不影响结果。方法：采用综合卫生经济评估报告标准（CHEERS）清单和卫生与医学成本效益第二小组的方法建议，构建决策分析模型，根据是否使用急诊科出院方案来预测MAP的医疗成本。结果：与标准护理住院相比，从急诊科出院的MAP平均节省了1720.5美元。假设67.7%的病例是轻微的，每年有288,820例AP住院治疗，急诊科出院途径将直接节省9860万美元的医疗费用。结论：为MAP实施循证、协议化的ED途径可直接节省1亿多美元的医疗费用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pancreatology 医学-胃肠肝病学

CiteScore

7.20

自引率

5.60%

发文量

194

审稿时长

44 days

期刊介绍： Pancreatology is the official journal of the International Association of Pancreatology (IAP), the European Pancreatic Club (EPC) and several national societies and study groups around the world. Dedicated to the understanding and treatment of exocrine as well as endocrine pancreatic disease, this multidisciplinary periodical publishes original basic, translational and clinical pancreatic research from a range of fields including gastroenterology, oncology, surgery, pharmacology, cellular and molecular biology as well as endocrinology, immunology and epidemiology. Readers can expect to gain new insights into pancreatic physiology and into the pathogenesis, diagnosis, therapeutic approaches and prognosis of pancreatic diseases. The journal features original articles, case reports, consensus guidelines and topical, cutting edge reviews, thus representing a source of valuable, novel information for clinical and basic researchers alike.